Back
ESC Premium Access

Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009-2017

Session: Cardiovascular Disease Prevention and Treatment: What Drives Change?
Topic: Public Health
Speaker: Doctor I. Thalmann (Oxford, GB)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Doctor Inna Thalmann

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom

Speaker: Doctor E. Sidelnkov (Rotkreuz, CH)

Access
Abstract
Slides
Video
Like
Thumbnail

Management of conflicts of interests of ESC guideline authors

Speaker: Professor H. Seggewiss (Wurzburg, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Burnout in residency: are cardiology residents more affected?

Speaker: Mr A. Sigal (Buenos Aires, AR)

Access
Abstract
Slides
Video
Like
Thumbnail

The assessment of the accuracy and credibility of cardiovascular health information on social media platforms

Speaker: Doctor A. Ragab (Rotterdam, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiovascular Disease Prevention and Treatment: What Drives Change?

Speakers: Doctor I. Thalmann, Doctor E. Sidelnkov, Professor H. Seggewiss, Mr A. Sigal, Doctor A. Ragab
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources